Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
Study NCT ID:
NCT04493060
Status:
COMPLETED
Last Update Posted:
2025-08-07
First Post:
2020-07-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-27
First Submit QC Date:
None
Study First Post Date:
2020-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-01
Results First Submit QC Date:
None
Results First Post Date:
2025-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-21
Last Update Post Date:
2025-08-07
Last Update Post Date Type:
ACTUAL